Trifluoroacetic acid → HCID 25167323, compound
Reaction equation
CCN(C(C)C)C(C)C.[C:10]1([NH:16][C:17]2[CH:25]=[CH:24][C:20]([C:21]([OH:23])=O)=[CH:19][CH:18]=2)[CH:15]=[CH:14][CH:13]=[CH:12][CH:11]=1.CCN=C=NCCCN(C)C.C1C=CC2N(O)N=NC=2C=1.[NH2:47][CH2:48][C:49]([N:51]1[CH2:56][CH2:55][N:54]([C:57](=[O:68])[C:58]2[CH:63]=[CH:62][CH:61]=[CH:60][C:59]=2[C:64]([F:67])([F:66])[F:65])[CH2:53][CH2:52]1)=[O:50].C(O)(C(F)(F)F)=O>CN(C=O)C.CCCCCC.O>[O:50]=[C:49]([N:51]1[CH2:52][CH2:53][N:54]([C:57](=[O:68])[C:58]2[CH:63]=[CH:62][CH:61]=[CH:60][C:59]=2[C:64]([F:67])([F:66])[F:65])[CH2:55][CH2:56]1)[CH2:48][NH:47][C:21](=[O:23])[C:20]1[CH:19]=[CH:18][C:17]([NH:16][C:10]2[CH:11]=[CH:12][CH:13]=[CH:14][CH:15]=2)=[CH:25][CH:24]=1Participants
Reactant 6
Product 1
Reagents, catalysts & solvents 3
Procedure
DIPEA (0.096 mL, 0.56 mmol) was added drop wise to 4-phenylamino-benzoic acid (47 mg, 0.22 mmol) in DMF (4 mL). EDCI (53 mg, 0.28 mmol) and HOBT (30 mg, 0.22 mmol) were added consecutively and, after 10 mins, 2-amino-1-[4-(2-trifluoromethyl-benzoyl)-piperazin-1-yl]-ethanone in its TFA salt form (80 mg, 0.19 mmol) was added. The resulting mixture was stirred at room temperature overnight. Water was then added the resulting solid filtered to afford 68 mg of crude product. Purification by column chromatography (using silica gel of mesh size of 60-120 and 80/20 EtOAc:Hexane as the eluent) afforded 45 mg (47% yield) of N-{2-Oxo-2-[4-(2-trifluoromethyl-benzoyl)-piperazin-1-yl]-ethyl}-4-phenylamino-benzamide. LC-MS purity: 96.8%. 1H-NMR (DMSO-D6): δ 8.6 (s, 1H), 8.3 (t, 1H), 7.8 (m, 5H), 7.6 (d, 1H), 7.3 (t, 2H), 7.2 (d, 2H), 7.1 (d, 2H), 6.9 (t, 1H), 4.1 (d, 2H), 3.6 (m, 4H), 3.4 (m, 2H), 3.1 (m, 2H).
Workup
- filtrationfiltered
- customto afford 68 mg of crude product
- customPurification by column chromatography (
Sources & evidence
- ORD record
- ord-c1ff4a4b284f4de3b882de5475cefbd7
- Source dataset
- uspto-grants-2010_11
- Patent number
- US07842696B2
Reaction notes
Loading…